小儿重症肺炎合并心衰及小儿哮喘临床治疗效果分析

Analysis of clinical effect of severe pneumonia complicated with heart failure and asthma in children

目的 分析小儿重症肺炎合并心力衰竭(心衰)及小儿哮喘的临床治疗效果。方法 甄选0.5~5.5岁患有重症肺炎合并心力衰竭的患儿42例以及哮喘患儿34例作为观察对象。42例重症肺炎合并心力衰竭患儿依照就诊顺序分为参照A组(采用基础治疗, 21例)与实验A组(实施多巴胺、多巴酚丁胺治疗, 21例);34例哮喘患儿依照就诊顺序分为参照B组(进行常规治疗, 17例)和实验B组(实行特布他林联合布地奈德雾化吸入治疗, 17例)。比较两种疾病各亚组治疗效果。结果 治疗后,重症肺炎合并心力衰竭患儿中实验A组与参照A组的总有效率分别为95.23%、71.43%,两组总有效率比较,差异显著(P<0.05)。治疗后,哮喘患儿中实验B组与参照B组的总有效率分别为94.12%、64.71%,两组总有效率比较,差异显著(P<0.05)。结论 小儿重症肺炎合并心力衰竭以药物治疗为主,同时应注意小儿重症肺炎和心力衰竭的治疗,以减少各种并发症的发生;联用特布他林与布地奈德雾化吸入治疗能全面提高小儿哮喘的整体疗效,提升患儿的生命质量。

Objective To analyze the clinical effect of severe pneumonia complicated with heart failure and asthma in children.Methods A total of 42 children aged 0.5-5.5 years with severe pneumonia complicated with heart failure and 34 children with asthma were included as observation subjects.According to the order of treatment,42 children with severe pneumonia complicated with heart failure were divided into reference group A(treated with basic treatment,21 cases)and experimental group A(treated with dopamine and dobutamine,21 cases),34 children with asthma were divided into reference group B(treated with routine treatment,17 cases)and experimental group B(terbutaline combined with budesonide aerosol inhalation therapy,17 cases)according to the order of treatment.The treatment outcomes for both diseases were compared among the subgroups.Results After treatment,the total effective rate of experimental group A and reference group A were 95.23%and 71.43%,and the difference between the two groups was significant(P<0.05).After treatment,the total effective rate of experimental group B and reference group B were 94.12%and 64.71%,and the difference between the two groups was significant(P<0.05).Conclusion The treatment of heart failure in children with severe pneumonia is mainly drug treatment,and attention should be paid to the treatment of severe pneumonia and heart failure in children,so as to reduce the occurrence of various complications.The combined treatment of terbutaline and budesonide aerosol inhalation can comprehensively improve the overall curative effect and improve the quality of life of children with asthma.